| scholarly article | Q13442814 |
| P2093 | author name string | Jan Nilsson | |
| Prediman K Shah | |||
| Bo Jansson | |||
| Roland Carlsson | |||
| Gunilla Nordin Fredrikson | |||
| Ingrid Söderberg | |||
| Irena Ljungcrantz | |||
| Alexandru Schiopu | |||
| Björn Frendéus | |||
| Zufan Araya | |||
| P2860 | cites work | Structure, function and regulation of the ABC1 gene product | Q28206405 |
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Atherosclerosis. the road ahead | Q29618972 | ||
| Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease | Q31135767 | ||
| Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences | Q31135771 | ||
| Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis | Q33207408 | ||
| Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis | Q33890402 | ||
| Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis | Q34737721 | ||
| Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. | Q42595633 | ||
| Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice | Q46804215 | ||
| Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice | Q46925888 | ||
| Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits | Q71231757 | ||
| Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression | Q74582600 | ||
| Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice | Q77231603 | ||
| Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events | Q79533802 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| lipoprotein | Q28350 | ||
| antibody | Q79460 | ||
| P304 | page(s) | 2313-2318 | |
| P577 | publication date | 2007-11-26 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice | |
| P478 | volume | 50 |
| Q37146276 | 2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in Atherosclerosis |
| Q35245132 | A mathematical model of atherosclerosis with reverse cholesterol transport and associated risk factors |
| Q38073528 | A perspective for atherosclerosis vaccination: is there a place for plant-based vaccines? |
| Q37866627 | Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets |
| Q37709623 | Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases |
| Q47720168 | Assessment of Carrot Callus as Biofactories of an Atherosclerosis Oral Vaccine Prototype |
| Q38346930 | Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges |
| Q46473311 | Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells |
| Q37953777 | Atherosclerosis: current pathogenesis and therapeutic options |
| Q37138017 | Autoimmunity in atherosclerosis: a protective response losing control? |
| Q91650985 | B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice |
| Q42382317 | Can Antibodies Protect Us Against Cardiovascular Disease? |
| Q38599711 | Computational modelling of atherosclerosis |
| Q49072554 | Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus. |
| Q34082315 | Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice |
| Q55404051 | Diet-Induced Abdominal Obesity, Metabolic Changes, and Atherosclerosis in Hypercholesterolemic Minipigs. |
| Q34342725 | Differential microRNA response to a high-cholesterol, high-fat diet in livers of low and high LDL-C baboons |
| Q37576750 | Experimental immunotherapeutic approaches for atherosclerosis. |
| Q33930928 | High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes |
| Q37248663 | Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccination |
| Q56986575 | Identifying needs and opportunities for advancing translational research in cardiovascular disease |
| Q36203882 | Immune response to lipoproteins in atherosclerosis |
| Q34528035 | Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice |
| Q37385727 | Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice |
| Q57132246 | Immunological aspects of atherosclerosis: Figure 1 |
| Q35174901 | Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice |
| Q90298329 | Inverse association of ApoB and HSP60 antibodies with coronary artery disease in Indian population |
| Q38846881 | Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis |
| Q37209541 | Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis |
| Q38125279 | Molecular biology of atherosclerosis |
| Q38834917 | Multi-radionuclide digital autoradiography of the intra-aortic atherosclerotic plaques using a monoclonal antibody targeting oxidized low-density lipoprotein |
| Q38210609 | Multiple potential roles for B cells in atherosclerosis |
| Q58692371 | New Alternatives for Atherosclerosis Treatment Based on Immunomodulation |
| Q98200234 | New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis |
| Q26822962 | Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis |
| Q33857831 | Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics |
| Q38912628 | Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis |
| Q35998510 | Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention |
| Q34428136 | Pharmacokinetics and biodistribution of a human monoclonal antibody to oxidized LDL in cynomolgus monkey using PET imaging |
| Q93012768 | Pneumococcal polysaccharide vaccine associated with reduced lengths of stay for cardiovascular events hospital admissions: Experience from the Hunter Community Study |
| Q38774904 | Readapting the adaptive immune response - therapeutic strategies for atherosclerosis |
| Q98471259 | Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr-/- mice |
| Q37173369 | Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques. |
| Q38406177 | Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis |
| Q85104084 | The B Cell in Atherosclerosis: Teaming Up with the Bad Guys? |
| Q35024665 | The Dynamics of Oxidized LDL during Atherogenesis |
| Q58586646 | The role of B cells in atherosclerosis |
| Q34631933 | The role of Siglec-1 and SR-BI interaction in the phagocytosis of oxidized low density lipoprotein by macrophages |
| Q36279562 | Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis |
| Q43263819 | Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. |
| Q38089941 | Vaccines against atherosclerosis |
| Q92287764 | [Immunity and inflammation in atherosclerosis] |
| Q37747331 | oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca2+ /K+ channel flow |
Search more.